$NOTE

FiscalNote Holdings, Inc. (NOTE) Reports Q2 Loss, Tops Revenue Estimates

FiscalNote Holdings, Inc. (NOTE) delivered earnings and revenue surprises of +11.11% and +1.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Original reporting
Zacks Commentary · Zacks Equity Research
Published Aug 7, 2025, 11:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2025, 2:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FiscalNote Holdings, Inc. (NOTE) Reports Q2 Loss, Tops Revenue Estimates — source image
Decision brief

The 30-second read

$NOTENeutralMed
01

Why it matters

The earnings beat indicates operational strength, which could lead to short-term stock appreciation; however, the neutral sentiment suggests limited long-term impact without additional positive catalysts.

02

Market read

The company's recent earnings report has moderate relevance for traders focusing on technology and data analytics sectors, with limited broader market implications.

03

What to watch

Potential upcoming earnings volatility, macroeconomic factors, and sector-specific risks that could offset the positive earnings surprise.

Timing: Immediate, given the recent earnings report and market reaction.

Background

FiscalNote Holdings, Inc. specializes in data analytics and technology solutions for government and public sector clients.

Company-level read

Ticker impact

$NOTENeutralMedium confidence
Context

Primary focus of the news, high relevance to current trading decisions.

Expected impact

Moderate upward movement in the short term, with potential for increased volatility.

Evidence & confidence

Earnings beat expectations, which typically supports price appreciation; however, the neutral sentiment and limited relevance scores suggest cautious optimism rather than strong bullish signals.

Market effects

Potential positive influence on the technology and data analytics sectors, where FiscalNote operates.

Limited; the impact is primarily localized to the company's stock and related sectors.

Low; the company's earnings report has minimal direct influence on global markets.

Counterpoint

The earnings beat may be a short-lived anomaly; the stock could revert to prior levels if broader market conditions deteriorate.

Key entities

  • FiscalNote Holdings, Inc.

    A provider of data analytics and technology solutions for government and public sector clients.

Related articles

$NOTEMed

FiscalNote Holdings, Inc. (NOTE): Results of Operations and Financial Condition

FiscalNote Holdings, Inc. (NOTE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 note-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FiscalNote Reports Second Quarter 2026 Financial Results Total Revenue In Line with Guidance; Adjusted EBITDA Slightly Below Guidance; Establishes Q3 2026 Forecast and Revises FY26 Guidance Company To Host Conference Call Tod

$BKRMed

Baker Hughes to Supply Subsea Systems for Kutei Northern Hub

Baker Hughes said it won a contract to supply subsea production systems and digital solutions for the Kutei Northern Hub offshore Indonesia. The deal with Searah North Ganal, a subsidiary of Searah Limited (JV of Eni and Petronas), covers 17 deepwater horizontal tree systems plus manifolds, control and distribution equipment, and Cordant asset protection and condition monitoring.

$DISMed

Disney, Comcast reach deal, lifting NFL Network blackout

Comcast and Disney reached an agreement to end the NFL Network blackout for Comcast Xfinity TV subscribers, resuming NFL Network and NFL RedZone in time for the 2026 season. The blackout began after their contract expired in late April. Disney owns 72% of ESPN, which took over NFL Media assets earlier this year. Terms were not disclosed.

$ABUSMed

Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?

Arbutus Biopharma (ABUS) received about $178 million from Moderna (MRNA) as its share of a $950 million noncontingent LNP patent settlement, with reimbursement of legal costs and an expected Q3 dividend tied to Genevant. ABUS reported Q1 2026 revenue of $179.1 million and net income of $169.7 million. Moderna reported Q2 2026 revenue of $145 million and a net loss of $782 million, plus FDA approval for mFLUSIVA.

$IONQMedAI 8/10

Pentagon may see one of quantum computing’s first practical winners

IonQ (IONQ) said DARPA awarded a $28 million contract modification under its It’s About Time program to support production development and 25 Evergreen-05 optical atomic clocks, with a $30 million option for 100 additional clocks. IonQ plans to invest $15 million to scale manufacturing. The company cites timing performance for GPS-denied defense uses.

$CCEYFMedAI 8/10

CanCambria Energy Provides Updated Contingent Resource Evaluation for Flagship Deep Gas Project, Attributable to Strong European Natural Gas Prices, Driving an Increased NPV10 of US$2.04 Billion

CanCambria Energy Corp. (TSXV: CCEC) reported an updated independent contingent resource evaluation for its 100% owned Kiskunhalas deep gas project in southern Hungary. Prepared by CHPE (effective June 30, 2026), it assumes $12.00/MMBtu TTF1 gas. Risked 2C Development Pending NPV10 rose 16% to US$2.04B from US$1.762B; 2C volumes are 571.9 Bcf and 59.6 MMbbl. First gas is targeted for mid-2027.